This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

FSAs Still Worthwhile Under New Rules

BERKELEY HEIGHTS, N.J. (TheStreet) -- Flexible Savings Arrangements were modified starting Jan. 1, a result of the health care legislation enacted a year ago, with over-the-counter medicines no longer qualifying for reimbursement unless you have a prescription. The only exception to the rule is insulin.

The new rule affects only purchases made after Jan. 1, though, so over-the-counter purchases made last year could still be reimbursed if allowed by an employer's FSA plan. (It should be noted this same rule also applies to Medical Savings Accounts, Health Savings Accounts and Health Reimbursement Arrangements.)

Nonprescription, over-the-counter drugs are no longer reimbursed through Flexible Savings Arrangements and the like, but the plans still have value.

On the upside, effective March 30 the FSA rules allow for someone under the age of 27 to qualify for expense reimbursement.

Do FSA plans still make sense, given the new rules? The answer is absolutely yes.

FSAs allow employees to set aside pretax dollars to pay for unreimbursed medical expenses. These plans typically have a maximum annual dollar contribution amount. FSAs are great for employees because they reduce their taxable income and are not subject to employment taxes. The accounts also provide a funding vehicle for unreimbursed medical expenses.

Reimbursable expenses still allowed from FSAs include items such as eyeglasses, dental work, contact lenses, co-pays and deductibles, so the loss of over-the-counter medications from the list is not so important. A person without an FSA normally would have to claim these expenses as an itemized medical deduction subject to 7.5% of their adjusted gross income. People are far better off getting their income reduced dollar for dollar rather than making an itemized deduction subject to a threshold.

With an FSA plan the most important factor is how much to contribute each year. People who contribute too much forfeit their unused balance, so someone using an FSA needs to figure out how much in qualifying medical expenses they will likely have in any given year. (Now, of course, when making contributions since 2010 they need to remove over-the-counter medications from their estimates.)

FSAs are still worthwhile, but make sure each year to do a projection of next year's projected expenses. Failure to do so may result in the accountholder forfeiting unused FSA balances.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:



Follow TheStreet.com on Twitter and become a fan on Facebook.

Michael Maye is the founder and president of MJM Financial Advisors, a registered investment advisory firm in Berkeley Heights, N.J. He is a member of the National Association of Personal Financial Advisors (NAPFA) and has been a speaker covering tax topics at NAPFA's national and regional conferences. Maye has also been a frequent contributor to the Star Ledger of New Jersey's 'Biz Brain' and 'Get With the Plan' articles. In addition to NAPFA, he is a member of Financial Planning Association, American Institute of Certified Public Accountants, New Jersey State Society of CPAs and the Estate Planning Council of Northern New Jersey.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,058.92 -20.65 -0.12%
S&P 500 1,999.94 +3.20 0.16%
NASDAQ 4,572.06 +14.3650 0.32%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs